Press Review

Multi-cytokine profiles inform treatment decisions

A commentary by Wolfgang Kintzel, Co-CEO of AYOXXA Biosystems

Proteomics is an indispensable tool to elucidate disease etiology. Understanding the molecular background of a disease enables the development of more effective drugs and precise, reliable diagnostics. Worldwide, researchers examine entire protein networks in cells and organisms to predict the outcome of perturbing pathway dynamics and translate this knowledge into powerful clinical applications.

Learn how multiplex protein profiling advances research in medical sciences. In a recent issue of MedNous, our Co-CEO Wolfgang Kintzel discusses a patient study carried out by Vassiliki A. Boussiotis and colleagues at the Beth Israel Deaconess Medical Center in Boston, USA, that used the LUNARIS™ Human 11-Plex Cytokine Panel to efficiently assess adult patients for the risk of graft-versus-host disease (GvHD) following umbilical cord blood transplantations.

(Download made available with permission from MedNous)

Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.